Telavancin
0101
Phase 2 small_molecule terminated
Quick answer
Telavancin for Gram-Positive Bacterial Infections is a Phase 2 program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- CUMBERLAND PHARMACEUTICALS INC
- Indication
- Gram-Positive Bacterial Infections
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated